Ignite Creation Date:
2025-12-25 @ 5:09 AM
Ignite Modification Date:
2025-12-26 @ 4:14 AM
Study NCT ID:
NCT02842827
Status:
COMPLETED
Last Update Posted:
2023-07-11
First Post:
2016-07-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)
Sponsor:
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-06
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10-30
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-12
First Submit QC Date:
None
Study First Post Date:
2016-07-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-05-23
Results First Submit QC Date:
None
Results First Post Date:
2023-07-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-10
Last Update Post Date:
2023-07-11
Last Update Post Date Type:
ACTUAL